Description of Medical ServiceCorneal collagen cross linking is a treatment first described about 10 years ago. It involves soaking of the cornea with a solution of riboflavin 0.1% and dextran. An ultraviolet A light source is shone onto the cornea. The effect is to increase inter molecular bonds between collagen fibres and stiffen the cornea reducing the risk of progression of ectasia.
Description of Medical ConditionKeratoconus is a condition that progresses in the late teens and early twenties and the cornea becomes progressively more ectatic and the vision deteriorates. Treatment may involve hard contact lenses. Eventually it may become impossible to fit or wear lenses and in this situation corneal transplantation may be required. Although a successful treatment corneal transplantation is a major operation with potentially significant risks to good vision. A treatment to slow progression of the disease is clearly desirable.
Reason for ApplicationNew MBS item
Medical Service TypeTherapeutic
Previous Application NumberNot Applicable
PICO ConfirmationFinal Protocol (PDF 146 KB)
Final Protocol (Word 297 KB)
Public Summary DocumentPublic Summary Document (PDF 234 KB)
Public Summary Document (Word 107 KB)
Meetings for this Application
PASC11 December 2014
16 April 2015